Fatemeh Gheybi

Dr. Fatemeh Gheybi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AGAtefeh Ghahremanloo
Atefeh Ghahremanloo
BEBahareh Erfani
Bahareh Erfani
FAFereshteh Asgharzadeh
Fereshteh Asgharzadeh
SMSaeide Mansoori
Saeide Mansoori
FGFatemeh Gheybi
Fatemeh Gheybi
SHSeyed Isaac Hashemy
Seyed Isaac Hashemy
This study investigates the efficacy and toxicity profiles of pegylated liposomal doxorubicin (Doxil) compared to conventional doxorubicin. Additionally, it evaluates the potential of combination therapy involving Doxil and doxorubicin with aprepitant, an FDA-approved agent for the management of chemotherapy-induced nausea and vomiting. Using a mouse model induced with 4T1 breast cancer cells, tumor size, and weight were assessed following treatment with either single doses or combination therapies. The study also examined oxidative and antioxidant stress markers in tumor, liver, and cardiac tissues, complemented by histopathological analysis of these tissues using hematoxylin and eosin staining. Results indicated that prepared liposomal doxorubicin significantly enhanced antitumor efficacy, as evidenced by decreased tumor size and weight. Moreover, it positively influenced oxidative stress markers, promoting apoptosis in tumor tissues. Notably, Doxil also reduced adverse effects compared to standard doxorubicin, as indicated by lower oxidative stress levels and increased antioxidant activity in both cardiac and liver tissues. The combined administration of doxorubicin and aprepitant further improved therapeutic efficacy and reduced side effects. Consequently, the formulation of doxorubicin in liposomes and aprepitant-based combination therapy represents a promising strategy for enhancing treatment effectiveness while minimizing adverse effects in breast cancer management.

1 December 2021 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
FGFatemeh Gheybi
Fatemeh Gheybi
SASeyedeh Hoda Alavizadeh
Seyedeh Hoda Alavizadeh
SRSeyed Mahdi Rezayat
Seyed Mahdi Rezayat
MHMahdi Hatamipour
Mahdi Hatamipour
JAJavad Akhtari
Javad Akhtari
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari

1 April 2021 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SHSaeed Mohammadian Haftcheshmeh
Saeed Mohammadian Haftcheshmeh
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari
MMMohammad Mashreghi
Mohammad Mashreghi
AMAmin Mehrabian
Amin Mehrabian
SASeyedeh Hoda Hoda Alavizadeh
Seyedeh Hoda Hoda Alavizadeh
FGFatemeh Gheybi
Fatemeh Gheybi

12 June 2023 in Drug Discovery Today
Verified
Journal Article
Closed access
AMAli Mahmoudi
Ali Mahmoudi
SASeyedeh Hoda Alavizadeh
Seyedeh Hoda Alavizadeh
SHSeyedeh Atefeh Hosseini
Seyedeh Atefeh Hosseini
PMPouria Meidany
Pouria Meidany
MDMaham Doagooyan
Maham Doagooyan
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar

25 April 2023 in IET Nanobiotechnology
Verified
Journal Article
Open access
ali mahmoudiali mahmoudi
ali mahmoudi
SSSeyedeh Belin Tavakoly Sany
Seyedeh Belin Tavakoly Sany
MSMarzieh Ahari Salmasi
Marzieh Ahari Salmasi
Ali BakhshiAli Bakhshi
Ali Bakhshi
ABArad Bustan
Arad Bustan
FGFatemeh Gheybi
Fatemeh Gheybi
The outbreak of COVID‐19 disease, the cause of severe acute respiratory syndrome, is considered a worldwide public health concern. Although studies indicated that the virus could spread through respiratory particles or droplets in close contact, current research have revealed that the virus stays viable in aerosols for several hours. Numerous investigations have highlighted the protective role of air purifiers in the management of COVID‐19 transmission, however, there are still some doubts regarding the efficiency and safety of these technologies. According to those observations, using a proper ventilation system can extensively decrease the spread of COVID‐19. However, most of those strategies are currently in the experimental stages. This review aimed at summarising the safety and effectiveness of the recent approaches in this field including using nanofibres that prevent the spread of airborne viruses like SARS‐CoV‐2. Here, the efficacy of controlling COVID‐19 by means of combining multiple strategies is comprehensively discussed.

10 July 2024 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SKSamin Khabbazian
Samin Khabbazian
EMElaheh Mirhadi
Elaheh Mirhadi
FGFatemeh Gheybi
Fatemeh Gheybi
AAAnis Askarizadeh
Anis Askarizadeh
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari
SASeyedeh Hoda Hoda Alavizadeh
Seyedeh Hoda Hoda Alavizadeh